Fresenius Medical Care plans to sell select assets of Spectra Laboratories to Quest Diagnostics as it exits non-core markets.
Fresenius Medical Care announced today that it agreed to sell select assets of its laboratory testing services to Quest ...
Fresenius Medical Care (XETRA: FME; NYSE: FMS), the world's leading provider of products and services for individuals with ...
Fresenius Medical (FMS) and Quest Diagnostics (DGX) announced that, under terms of a definitive acquisition agreement, Quest will acquire ...
Hims & Hers is expanding its offerings through the Trybe Labs deal after it added compounded weight loss drugs.
The acquisition will add dialysis-related water testing to Quest’s portfolio and position the company to perform the tests ...
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as ...
GRAIL's Galleri Test Now Directly Available to Physicians in the U.S. Through Collaboration With Quest Diagnostics, Delivering a More Streamlined Provider and Patient Experience MENLO PARK ...
Grail (GRAL) and Quest Diagnostics (DGX) announced the initial phase of a program to improve provider access to GRAIL’s Galleri multi-cancer ...
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, recently announced that it has been selected as one of the 2025 World's Most Admired Companies™ by Fortune® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback